These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 12608473)
21. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Berry DP; Clarke P; Hardcastle JD; Vellacott KD Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712 [TBL] [Abstract][Full Text] [Related]
22. [Early detection of adenomas in asymptomatic subjects: flexible sigmoidoscopy or colonoscopy]. Farca Belsaguy A; Presenda Miller F; de la Mora Levy G Rev Gastroenterol Mex; 1996; 61(1):27-30. PubMed ID: 8685586 [TBL] [Abstract][Full Text] [Related]
23. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
24. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire]. Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850 [TBL] [Abstract][Full Text] [Related]
25. [Randomized controlled trial of sequence mass screening program for colorectal cancer]. Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828 [TBL] [Abstract][Full Text] [Related]
26. Fecal occult blood testing: clinical value and limitations. Simon JB Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575 [TBL] [Abstract][Full Text] [Related]
28. Outcomes for women in a flexible sigmoidoscopy-based colorectal cancer screening programme. Viiala CH; Olynyk JK Intern Med J; 2008 Feb; 38(2):90-4. PubMed ID: 17916176 [TBL] [Abstract][Full Text] [Related]
30. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer]. Tazi MA; Faivre J; Lejeune C; Dassonville F; Benhamiche AM Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Schroy PC; Wilson S; Afdhal N Am J Gastroenterol; 1996 Jul; 91(7):1331-7. PubMed ID: 8677989 [TBL] [Abstract][Full Text] [Related]
32. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A; Young GP; Cole SR; Bampton P Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938 [TBL] [Abstract][Full Text] [Related]
33. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Rozen P; Knaani J; Samuel Z Cancer; 2000 Jul; 89(1):46-52. PubMed ID: 10896999 [TBL] [Abstract][Full Text] [Related]
34. Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Pinsky PF; Schoen RE; Weissfeld JL; Bresalier RS; Hayes RB; Gohagan JK Clin Gastroenterol Hepatol; 2003 Mar; 1(2):103-10. PubMed ID: 15017502 [TBL] [Abstract][Full Text] [Related]
35. Offering people a choice for colorectal cancer screening. Senore C; Ederle A; Benazzato L; Arrigoni A; Silvani M; Fantin A; Fracchia M; Armaroli P; Segnan N Gut; 2013 May; 62(5):735-40. PubMed ID: 22442162 [TBL] [Abstract][Full Text] [Related]
36. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G Scand J Gastroenterol; 2003 Jun; 38(6):635-42. PubMed ID: 12825872 [TBL] [Abstract][Full Text] [Related]
37. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Farraye FA; Horton K; Hersey H; Trnka Y; Heeren T; Provenzale D Am J Gastroenterol; 2004 Jun; 99(6):1074-80. PubMed ID: 15180728 [TBL] [Abstract][Full Text] [Related]
38. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Thiis-Evensen E; Hoff GS; Sauar J; Majak BM; Vatn MH Am J Gastroenterol; 2001 Jun; 96(6):1901-7. PubMed ID: 11419846 [TBL] [Abstract][Full Text] [Related]
39. Screening for colorectal cancer. Hakama M; Hoff G; Kronborg O; Påhlman L Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076 [TBL] [Abstract][Full Text] [Related]
40. [Requirement of hospital beds in connection with screening for colorectal cancer. The first 5-years of a randomized population survey]. Bech K; Kronborg O Ugeskr Laeger; 1992 Mar; 154(11):696-9. PubMed ID: 1546398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]